Stop The Black Market Drug Trade From Destroying Lives And Endangering Animal Care

1,529 signatures toward our 30,000 goal

5.096666666666667% Complete

Sponsor: The Animal Rescue Site

Drugs like xylazine and medetomidine are causing catastrophic injuries, overwhelming responders, and threatening the medications veterinarians need to save animals—take action before this crisis deepens beyond control.

Stop The Black Market Drug Trade From Destroying Lives And Endangering Animal Care

Drugs like xylazine and medetomidine are spreading through the illicit drug supply in Massachusetts and across the country with brutal speed. This veterinary sedative is not approved for human use, yet it is now mixed into street fentanyl and sold without disclosure. People are collapsing into overdoses that resist naloxone, suffering deep necrotic wounds, and overwhelming emergency responders who were never trained to treat these effects.1 Communities face a crisis they did not create and cannot ignore.

State testing shows how quickly this danger has grown. In Massachusetts, xylazine appeared in more than a third of lab-tested samples last year and was linked to a rising share of opioid-related deaths.2 Many people exposed to it never intended to take it. They learn the truth only after a medical emergency or the appearance of sudden, aggressive wounds.

At the same time, the illicit market is shifting again. A second veterinary tranquilizer—medetomidine—has begun surfacing in overdose clusters in cities across the country.3 It is even more potent than xylazine and causes withdrawal symptoms that standard opioid treatments cannot control. Without immediate action, Massachusetts risks facing a dual-sedative drug crisis that will strain every part of the public health system.

Veterinarians depend on these medications to safely sedate horses, cattle, dogs, and wildlife. Diversion threatens not only human health but the animals who rely on these drugs for surgery, emergency restraint, and relief from pain.4 If supplies tighten because of illicit misuse, clinics could struggle to care for animals humanely and safely.

We Need Action Now

Massachusetts needs stronger surveillance, public education, widespread access to xylazine test strips, clear clinical guidelines, and rapid-response wound care. Closing loopholes that allow bulk purchases and strengthening distribution controls will reduce diversion without harming legitimate veterinary access.

This requires compassion for the people losing their lives to a contaminated drug supply and responsibility for the animals whose medical care depends on these sedatives. Protecting both demands decisive action today.

Sign the Petition

Add your name and urge the Massachusetts Department of Public Health to implement emergency and permanent measures that protect every community, prevent further injuries and deaths, and preserve safe veterinary access for animals who need this medication.

Sign now to help ensure a safer future for all.

MORE ON THIS ISSUE:

  1. Deborah Rod, GovFacts (1 December 2025), “Xylazine: The Animal Tranquilizer Making Fentanyl Even Deadlier.”
  2. James Paleologopoulos, WAMC (25 June 2025), “Special Mass. Commission Holds Hearing on Spread, Effects of Xylazine in Illicit Drug Supply.”
  3. AVMA News, AVMA (23 June 2025), “Health Officials Finding Different Illicit Veterinary Sedative in US Drug Supply.”
  4. Dunn et al., Brain Sciences (10 February 2025), “From Veterinary Medicine to Illicit Drug Supply.”

The Petition

To the Massachusetts Department of Public Health,

Xylazine’s rapid and dangerous emergence in the illicit drug supply has created an urgent public health crisis in our Commonwealth. Testimony and data presented to the Special Commission on Xylazine show widespread detections across multiple regions of the state and an alarming rise in overdose deaths in which this veterinary sedative is a contributing factor. Xylazine is not approved for human use, yet it is being routinely mixed with street fentanyl and sold without disclosure. People are suffering medical emergencies that first responders are not fully equipped to treat, including deep skin wounds, prolonged respiratory depression, and naloxone-resistant overdoses.

We ask the Department of Public Health to implement emergency and permanent measures that respond decisively to this threat. These steps should include:

  • Expanded public education on xylazine’s dangers and its resistance to naloxone.
  • Widely accessible, reliable xylazine test strips and distribution through non-stigmatizing locations.
  • Standardized clinical protocols for detection, wound care, and overdose management.
  • Enhanced surveillance for both xylazine and emerging veterinary adulterants such as medetomidine.
  • Tighter controls on bulk sales and distribution channels that enable diversion, paired with strong protections for legitimate veterinary use.
  • Investment in mobile wound care units, community drug-checking programs, and rapid-response harm-reduction services.

These actions will protect people who are unknowingly exposed to a sedative they never intended to take and will support first responders, clinicians, and outreach workers who face unprecedented medical challenges. They will also help preserve access for veterinarians who depend on xylazine to safely treat horses, cattle, wildlife, and companion animals. Responsible regulation must safeguard the animals who rely on this medication while stopping the pathways that channel it into the illicit market.

At the heart of this crisis is the need for compassion and humanity. Many individuals exposed to xylazine are not seeking it; they are victims of a drug supply that has grown more unpredictable and more dangerous. They deserve care, dignity, and a system prepared to keep them alive long enough to seek recovery.

By closing loopholes, strengthening clinical readiness, and prioritizing humane, evidence-based responses, Massachusetts can prevent further injuries and deaths. These steps will create a safer, healthier, and more resilient future—one that protects our communities and ensures responsible, humane care for all.

Sincerely,

DEV MODE ACTIVE. BRAND: gg